Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoriasis Treated with Biologics
JID, 2023.
Al-Janabi A, Eyre S, Foulkes AC, Khan AR, Dand N, Burova E, DeSilva B, Makrygeorgou, Davies E, Smith CH, Griffiths CEM, Morris AP, Warren RB; BSTOP & BADBIR Study Groups.
Read publication: JID
Related
Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study...
Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000...
The British Association of Dermatologists Biologics and Immunomodulators Register: a centenary celeb...
0 Comments